title: Belgian consensus on metabolic problems associated with atypical antipsychotics.
abstract: A workshop was convened by a panel of psychiatrists, diabetologists and pharmacists from major Belgian hospitals to review the latest information relating to the risks with second-generation antipsychotics (SGA) for the development of metabolic disorders, especially impaired glucose tolerance, diabetes mellitus and dyslipidemia. The panelists sought to formulate recommendations for practising psychiatrists when initiating and maintaining therapy with SGA, and for the switch of SGA or initiation of further treatment if metabolic complications occur. In addition, recommendations for counselling of the patient and for the cooperation between the psychiatrist and the general physician or diabetologist, respectively, were provided.
authors.affiliation: Hôpital Sainte-Thérèse, Montignie sur Sambre, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: De Nayer
authors.forename: M
authors.initials: M
authors.lastname: De Hert
authors.forename: A
authors.initials: A
authors.lastname: Scheen
authors.forename: L
authors.initials: L
authors.lastname: Van Gaal
authors.forename: J
authors.initials: J
authors.lastname: Peuskens
authors.lastname: On Behalf Of The Consensus Group
authors.forename: A
authors.initials: A
authors.lastname: De Nayer
authors.forename: M
authors.initials: M
authors.lastname: De Hert
authors.forename: A
authors.initials: A
authors.lastname: Scheen
authors.forename: L
authors.initials: L
authors.lastname: Van Gaal
authors.forename: J
authors.initials: J
authors.lastname: Peuskens
authors.lastname: On Behalf Of The Consensus Group
keywords: Consensus; diabetes; dyslipidemia; metabolic; second-generation antipsychotics